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Abstract
In small hibernators, global downregulation of the endocannabinoid system (ECS), which is involved in modulating
neuronal signaling, feeding behavior, energy metabolism, and circannual rhythms, has been reported to possibly
drive physiological adaptation to the hibernating state. In hibernating brown bears (Ursus arctos), we hypothesized
that beyond an overall suppression of the ECS, seasonal shift in endocannabinoids compounds could be linked to
bear’s peculiar features that include hibernation without arousal episodes and capacity to react to external
disturbance. We explored circulating lipids in serum and the ECS in plasma and metabolically active tissues in free-
ranging subadult Scandinavian brown bears when both active and hibernating. In winter bear serum, in addition to
a 2-fold increase in total fatty acid concentration, we found significant changes in relative proportions of circulating
fatty acids, such as a 2-fold increase in docosahexaenoic acid C22:6 n-3 and a decrease in arachidonic acid C20:4 n-
6. In adipose and muscle tissues of hibernating bears, we found significant lower concentrations of 2-
arachidonoylglycerol (2-AG), a major ligand of cannabinoid receptors 1 (CB1) and 2 (CB2). Lower mRNA level for
genes encoding CB1 and CB2 were also found in winter muscle and adipose tissue, respectively. The observed
reduction in ECS tone may promote fatty acid mobilization from body fat stores, and favor carbohydrate
metabolism in skeletal muscle of hibernating bears. Additionally, high circulating level of the endocannabinoid-like
compound N-oleoylethanolamide (OEA) in winter could favor lipolysis and fatty acid oxidation in peripheral tissues.
We also speculated on a role of OEA in the conservation of an anorexigenic signal and in the maintenance of
torpor during hibernation, while sustaining the capacity of bears to sense stimuli from the environment.
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Background
To deal with seasonal cold and food shortage during win-
ter, hibernating mammals show a combination of behav-
ioral and physiological changes. To save energy during
hibernation, hibernating animals use periods of torpor
characterized by decreased metabolic rate and body
temperature, reduction in respiratory and heart rates, and
physical inactivity [1, 2]. Brown bears (Ursus arctos)
exhibit unique features, as they hibernate at mild
hypothermia (32–35 °C) and can stay inside their dens for
up to 7months, without drinking, eating, defecating or
urinating, and with no arousal episodes [3–6]. While den-
ning, they reduce their metabolic rate by about 75% [7],
and rely primarily on mobilization of fat stores, which is
reflected by increased circulating fatty acid concentration
and body fat store depletion during winter [8–10].
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Beyond energy substrates, lipids also have pleiotropic ac-
tions in the regulation of metabolism, and changes in mem-
brane fatty acid composition have already been described in
hibernating animals [11–14], including the brown bear [9].
Membrane phospholipids can also provide long-chain fatty
acids for the synthesis of bioactive lipid mediators, such as
endocannabinoids [15–17]. The endocannabinoid system
(ECS) was originally described as being composed of G-
protein coupled receptors (CB1 and CB2) and their
endogenous ligands, of which the main ones are derived
from arachidonic acid 20:4n-6 (AA) esterified into phos-
pholipids, and called 2-arachidonoyl glycerol (2-AG) and
anandamide (AEA) [15–20]. These two well-characterized
compounds clearly show varying affinity for CB1 and CB2
receptors. Indeed, AEA is considered as a high affinity
CB1-partial agonist (and weak CB2 agonist), whereas 2-AG
is described as a low-to-moderate affinity CB1 and CB2 full
agonist [21, 22]. 2-AG and AEA belong to the large family
of 2-acylglycerols (2-AcGs) and N-acylethanolamines
(NAEs), respectively [17, 19]. N-acyl-
phosphatidylethanolamine-hydrolyzing phospholipase D
(NAPEPLD) and sn-1-specific diacylglycerol lipase-α and β
(DAGLA and DAGLB) are the main enzymes involved in
the biosynthesis of NAEs and 2-AcGs, respectively [17, 19].
Fatty acid amide hydrolase (FAAH) is responsible for NAEs
catabolism (and to a lesser extend for 2-AG) [23], and
monoacylglycerol lipase (MGLL) specifically catabolizes 2-
AcGs [17, 19]. eCBs can also be metabolized by lipoxy-
genases (LOXs) and by cyclooxygenase-2 (COX-2), an al-
ternative pathway for eCBs catabolism [17].
The ECS includes structurally related compounds like N-
oleoylethanolamine (OEA), called «endocannabinoids-like
compounds» (eCBs-like). The latter are metabolized by the
same biosynthetic and catabolic enzymes as eCBs [17].
Although eCBs-like compounds are not able to bind to
CB1 and CB2 receptors, they can bind to other G-protein
coupled receptors (e.g. GPR119 and GPR55) or nuclear
receptors, like peroxisome proliferator-activated receptor α
(PPARA) [17].
Endogenous cannabinoids are involved in the regulation
of many physiological processes, including neuronal signal-
ing [24], stress response [25], metabolism [25–27], feeding
behavior and energy storage [25, 28]. Evidences support
the fact that the ECS could be involved in sleep cycles [29],
circadian and potentially circannual rhythms [30]. At the
central level (e.g. hypothalamus), CB1 is able to promote
food intake and reduce energy expenditure [25, 31]. In
addition, CB1 activation in adipose tissue leads to fatty acid
and glucose uptake, and to upregulation of lipogenesis [25].
In liver, CB1 signaling leads to increased expression of
genes involved in the synthesis of fatty acids [32], and in
skeletal muscle tissue, CB1 activation triggers a decrease in
glucose uptake and insulin sensitivity [25]. The CB2 recep-
tor is well known to be widespread over immune cells and
to have numerous immunomodulatory roles [33]. CB2 has
also been detected in metabolic tissues, like adipose tissue
and skeletal muscle [34, 35] and CB2 pharmacological or
genetic inactivation in murine obesity models promote
insulin-mediated glucose uptake in skeletal muscles, reduce
adipose tissue inflammation, and thus improves insulin
sensitivity [36, 37]. Finally, the eCB-like OEA promotes lip-
olysis, fatty acid oxidation in skeletal muscle and liver, and
triggers an anorexigenic signal, notably through the nuclear
receptor PPARA [38, 39]. Considering the pleiotropic roles
of ECS in neuronal signaling, regulation of feeding behav-
ior, energy metabolism and circannual rhythms, important
changes are expected during hibernation. Several ECS cir-
culating compounds have been quantified in hibernating
black bears, during and around the torpor phase [40],with
no major changes observed except a slight increase in 2-
AG in the period of metabolic drop before torpor. Al-
though a decrease in ECS tone has been observed in hiber-
nating marmots (Marmota monax and flaviventris) and
ground squirrels (Spermophilus richardsonii) [30, 41, 42],
we hypothesize that a similar decrease should occur in hi-
bernating bears, not excluding specific changes due to their
unique features during hibernation (mild hypothermia, no
periodic arousal, and maintenance of alertness). Therefore,
we explored here seasonal variations in fatty acid compos-
ition and ECS tone, in both circulating compartment and
in muscle and adipose tissues, in winter-hibernating and
summer-active brown bears.
Results
Seasonal differences in serum lipids
We explored the fatty acid (FA) composition of winter-
hibernating (WBS) and summer-active (SBS) bear serum
(see supplementary Table S1). From the lipidomic data,
we compared both the summer and winter concentrations
and proportions of fatty acids (see supplementary Table
S2 and S3 for detailed lipidomic results). As shown in
Fig. 1a, the total concentration of FAs was about twofold
higher in WBS relative to SBS (28.82 ± 1.71 vs. 15.99 ±
1.09mmol/L). All but two quantified lipid species were
higher in concentration in hibernating bears, i.e. saturated
fatty acids (SFAs), monounsaturated fatty acids (MUFAs),
and n-6 polyunsaturated fatty acids (PUFAs) (Supplemen-
tary Table S2). Only concentrations of alpha-linolenic acid
C18:3 n-3 (ALA) (0.49 -fold, non-significant) and eicosa-
pentaenoic acid C20:5 n-3 (EPA) (0.26-fold) were lower in
WBS (Supplementary Table S2).
Meanwhile, the molar percent of total n-6 species were
found to be lower in WBS compared to SBS (Fig. 1b). Lipid
species with the highest molar percent are presented in Fig.
1c (see Supplementary Table S3). Among SFAs, palmitic
acid C16:0 (PA) was found in higher proportion, whereas
stearic acid C18:0 (SA) was in lower proportion in winter
serum. Similar proportions of oleic acid 18:1n-9 (OA),
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belonging to the n-9 MUFAs, were found in winter and
summer bear serum. Concerning n-6 PUFAs, the proportion
of arachidonic acid C20:4 n-6 (AA) was lower during winter,
whereas proportion of linoleic acid C18:2 n-6 (LA) remained
unchanged (Fig. 1c). For individual species of the n-3 family
(Fig. 1d and Supplementary Table S3), docosapentaenoic acid
C22:5 n-3 (DPA, 1.5-fold) and docosahexaenoic acid C22:6
n-3 (DHA, 2.2-fold) were found in higher proportions.
The proportion of C20:5 n-3 (EPA) was found much
lower (0.15-fold) in winter serum, as well as the alpha-
linolenic acid C18:3 n-3 (ALA, 0.27-fold), a precursor of
the EPA, DPA and DHA species.
From molar percent values, the DHA/AA ratio was
3.2-fold higher in winter (Fig. 1e).
Changes in plasma endocannabinoids and
endocannabinoids-like compounds
We next assessed circulating eCBs and eCBs-like in bear
plasma. Paired samples were collected in winter and in
summer from eight bears (Supplementary Table S1) and
quantification of AEA, 2-AG and OEA are presented in
Fig. 2 and supplementary Table S5. Lower concentra-
tions were observed for AEA (0.63-fold) in winter com-
pared to summer, whereas the reverse was observed for
OEA (3.3-fold). No difference was found for 2-AG
plasma concentration.
Changes in endocannabinoid concentrations in muscle
and adipose tissues
Quantification of endocannabinoids was then performed
in bear muscle and adipose tissues. Paired tissues sam-
ples were collected from bears in winter and in summer
(Supplementary Table S1) and quantification of AEA, 2-
AG and OEA are presented in Fig. 3 and supplementary
Table S5. AEA concentration was lower in both muscle
and adipose tissues during winter versus summer, close
to the statistical threshold (p = 0.064 and p = 0.069, re-
spectively). 2-AG concentration was significantly lower
in muscle and adipose tissues samples during winter, by
about 1.6- and 9-fold, respectively. By contrast, no sea-
sonal changes were found in OEA concentrations in
both muscle and adipose tissues.
Changes in endocannabinoid pathway-related gene
expressions in muscle and adipose tissues
To explore tissue metabolism of endocannabinoids, we
quantified gene expression in muscle and adipose tissue
of the eCBs membrane receptors CB1 and CB2, and sev-
eral enzymes involed in the synthesis and catabolism of
eCBs. For muscle tissue, paired samples were from 8
bears at the two time points, while for adipose tissue,
data are coming from 5 bears in summer and 13 bears
(See figure on previous page.)
Fig. 1 Lipidomic from summer and winter brown bear serum. The winter and summer bear serum mixes were prepared as described (Supplementary
Table S1). a: Total fatty acid (FA) concentration. b: Total n-6 and n-3 FA relative proportions of total lipids. c: Highest molar percent lipid species D:
Molar percent of the n-3 family lipid species. e: Molar ratios of DHA/AA in summer and winter serum. Detailed lipidomic results are presented in
Supplementary Tables S2 and S3. Data are expressed in mmol/L for total FAs concentration, or molar percentage of total lipids and are represented as
mean ± SEM of separate extractions and quantifications from the twelve mixes (six summer and six winter serum mixes, except for EPA with data from
only three summer and three winter mixes). Paired Student t-test were used to compare wummer and winter data and Benjamini-Hochberg
correction was applied for multiple comparisons. * indicates BH adjusted p value < 0.05 when comparing seasons, ** for p < 0.01, *** for p < 0.001, NS:
non significant. AA:arachidonic acid, ALA: alpha-linolenic acid, DHA: docosahexaenoic acid, DPA: docosapentaenoic acid, EPA: eicosapentaenoic acid,
LA: linoleic acid, OA: oleic acid, PA: palmitic acid, SA: stearic acid, SBS: summer bear serum, WBS: winter bear serum
Fig. 2 Circulating endocannabinoids concentration in brown bear plasma. Concentration of three major endocannabinoids compounds in bear
plasma. Plasma were collected from bears at both winter-hibernating and summer-active time points (Supplementary Table S1). Data are
expressed in ng/mL and are represented as mean ± SEM of separate extractions and quantifications (n = 8). Paired Student t-test were used to
compare wummer and winter data. * indicates p value < 0.05 when comparing seasons, *** for p < 0.001, NS: non significant. AEA: anandamide,
2-AG: 2-arachidonoylglycérol, eCBs: endocannabinoids, OEA: N-oleoylethanolamine, SBP: summer bear plasma, WBP: winter bear plasma
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in winter (Supplementary Table S1). Data are presented
in Fig. 4 and Supplementary Table S5.
For genes that encode the membrane receptors CB1 and
CB2 in muscle tissue, CNR1 mRNA level, but not CNR2,
was decreased (0.63-fold) in winter (Fig. 4). Concerning en-
zymes that catabolize AEA and 2-AG, mRNA level of
FAAH was induced (2.3-fold) in winter, but MGLL gene ex-
pression did not change. For genes encoding enzymes of the
biosynthetic pathway, DAGLA mRNA level was strongly re-
duced in muscle tissue during winter (0.40-fold), whereas
DAGLB mRNA level was increased (1.53-fold). Finally, gene
expression of NAPEPLD did not change in muscle (Fig. 4).
Conversely, in adipose tissue (Fig. 5), no significant
changes in CNR1 gene expression were reported whereas
CNR2 expression was strongly decreased in winter (0.42-
fold). For gene expression of catabolic enzymes (FAAH
and MGLL), did not change in adipose tissue between sea-
sons. Finally, for genes encoding biosynthetic enzymes,
mRNA levels of DAGLB and NAPELD were respectively
found higher (1.44-fold) and lower (0.75-fold) in winter.
Discussion
Thanks to repeated capture sessions, we were able to gather
samples of serum, plasma and tissues from high number of
free-living brown bears (Ursus arctos). From the 28 bears
included in this study, samples were collected both in Feb-
ruary during winter hibernation and in June during summer
active period. Due to limited amount of available biological
material, the analyses were performed on samples coming
from different subsets of the 28 bears. In all but adipose tis-
sue, analyses were performed on winter and summer paired
samples (Supplementary Table S1). We examined circulat-
ing lipid and ECS compounds in both summer-active and
winter-hibernating brown bears to explore the extent to
which regulation of the ECS reflects bear hibernation pecu-
liarities, including survival due to lipid oxidation, mainten-
ance of muscle glycolysis, and maintained alertness during
dormancy. The seasonal shift we highlighted in serum FAs
composition, together with a decrease in tissue AEA and 2-
AG, and a three-fold increase in circulating OEA during
winter, could contribute to the behavioral and metabolic
changes that occur in hibernating bears.
Hibernators experience extended periods of food short-
age during hibernation and primarily rely on mobilization
of fat stores from white adipose tissue [1]. Accordingly, we
found that the concentration of total circulating fatty acids
was elevated in hibernating bears, a finding in line with
previous studies [5, 43]. Considering both the amount and
Fig. 3 Endocannabinoids concentration in brown bear muscle and adipose tissue. Concentration of three major endocannabinoids compounds in bear
muscle and adipose tissue. Tissues were collected from bears at both winter-hibernating and summer-active time points (Supplementary Table S1). Data
are expressed in pg/mg and are represented as mean ± SEM of separate extractions and quantifications (n = 5 for muscle tissue and n = 6 for adipose
tissue). Paired Student t-test were used to compare wummer and winter data. *** indicates p value < 0.0001 when comparing seasons, NS: non significant.
AEA: anandamide, 2-AG: 2-arachidonoylglycérol, OEA: N-oleoylethanolamine, SBA: summer bear adipose tissue, SBM: summer bear muscle, WBA: winter
bear adipose tissue, WBM: winter bear muscle
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relative proportions of circulating lipids, our results are
consistent with changes in serum and plasma lipid pro-
files during hibernation that have been previously pub-
lished [5, 9, 10], notably an enrichment in DHA C22:6
n-3 and depletions in ALA C18:3 n-3 and EPA C20:5
n-3, during winter compared to summer. Whether the
depletion in the ALA and EPA precursor species could
be directly linked to the observed DHA increase re-
mains to be elucidated.
Here, the DHA serum enrichment that we observed in
hibernating bears is actually not coming from dietary FAs
intake but rather due to lipid stores mobilization. The
health benefits that have been attributed to n-3 PUFAs (e.g.
DHA), essentially triggered by DHA dietary intervention
studies, could potentially be transposed in the context of
hibernation. Indeed, it has already been hypothesized that
DHA could be involved in the bear’s resistance to muscle
atrophy during hibernation [10]. DHA appears to prevent
muscle atrophy in fasting mice, and increases muscle glyco-
gen stores [44]. Strikingly, in parallel to DHA serum en-
richment, hibernating bears have more than a 3-fold higher
glycogen muscle content compared to summer-active ani-
mals [10]. In addition to its anti-inflammatory effects, DHA
is also known to exert a positive effect on protein balance
by decreasing expression of factors involved in protein
breakdown [45] and enhancing protein synthesis, notably
by promoting mammalian Target Of Rapamycin (mTOR)
activation [46].
Concomitantly to serum DHA enrichment, we observed
a drop in AA proportion, thus leading to a sharp increase
in the DHA/AA ratio. Omega-3/omega-6 ratio is known
to have an impact on global health [47], and the balance
of this ratio could also impact the endocannabinoid sys-
tem [48], notably because AA is a precursor of the two
main eCBs 2-AG and AEA. Indeed, n-6 PUFAs-enriched
diets have been shown to increase the level of 2-AG or
AEA in the brain, plasma, and peripheral tissues in non-
hibernating animal models [49–52]. It is noteworthy to
mention that, in response to DHA supplementation, an
enrichment of this fatty acid in phospholipids of cell
membranes occurs in parallel with a decrease in AA con-
tent [38, 49, 53, 54]. By remodeling the amount of AA-
containing phospholipids, DHA is able to reduce the syn-
thesis of AEA and 2-AG [49, 54]. Further studies on bears,
focusing on fatty acid membrane composition in tissues at
different time points, will be helpful to characterize the
Fig. 4 Fold change in gene expression of target genes involved in endocannabinoids biosynthesis and catabolism in brown bear muscle tissue.
Muscle tissues were collected from bears at both winter-hibernating and summer-active time points (Supplementary Table S1), total RNA was
extracted and expression levels were measured by RT-qPCR. Data are normalized against TBP mRNA levels and expressed as a fold change
relative to the summer condition, represented as mean ± SEM of separate extractions and quantifications (n = 8). Paired Student t-test were used
to compare wummer and winter data. * indicates p value < 0.05 when comparing seasons, NS: non significant. CNR1: cannabinoid receptor 1,
CNR2: cannabinoid receptor 2, DAGLA: diacylglycerol lipase alpha, DAGLB: diacylglycerol lipase beta, FAAH: fatty acid amide hydrolase, MGLL:
monoacylglycerol lipase, NAPEPLD: N-acyl phosphatidylethanolamine phospholipase D, SBM: summer bear muscle, WBM: winter bear muscle
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remodeling of membrane lipids that could affect the avail-
ability of FAs precursors for eCBs biosynthesis. Data on
eCBs compounds from experimental short fasting in non-
hibernating mammals are very divergent, depending on
the tissue considered (e.g. brain or peripheral tissues) and
the duration of food deprivation, but tissue levels of eCBs
are mainly regulated by the availability of their membrane
phospholipid precursors and by the activity of biosynthetic
and catabolic enzymes [28, 49, 55, 56].
We hypothesized that drastic reduction in metabolic
activity, lack of intake of dietary PUFAs, significant in-
crease in the serum DHA/AA ratio, and perhaps reduc-
tion in tissue AA-phospholipids concentration, could
lead to a global reduction in ECS tone during the hiber-
nation period. The reduction in ECS tone has already
been documented in hibernating marmots [30, 41], but
not confirmed in large-bodied hibernators.
Comparing active and hibernation states in brown
bears, we reported here a decrease in plasma concentra-
tion of AEA, and an unexpected 3-fold increase in OEA
circulating levels in hibernating bears. In both muscle
and adipose tissues, 2-AG and AEA (close to statistical
threshold) were found lower in winter, while OEA did
not change. Quantification of winter serum eCBs was
previously reported in black bears during and around
the topor phase, but summer active bears were not in-
vestigated [40]. Nutritional status of the captured ani-
mals and diet were not specified. These elements
strongly limit comparison between the two studies.
Taken together, our data allowed us to make several hy-
potheses about possible mechanisms by which ECS could
contribute to the metabolic and behavioral changes that
occur in bears during hibernation. First, considering that
AEA and 2-AG CB1 agonists favor food intake and stimu-
late lipogenesis [25], CB1 signaling is expected to be upreg-
ulated during the active summer period in order to
promote energy storage, and downregulated during winter
hibernation to stimulate lipolysis and FAs oxidation. The
tissue concentration drops in 2-AG and AEA observed
during winter could be due to a decrease in tissue AA-
phospholipids concentration, as we hypothesized above.
The degradation of AEA could also be increased in muscle
tissue during hibernation, as reflected in the higher mRNA
levels of FAAH, the main hydrolase that degrades AEA [19,
23]. In adipose tissue, lower NAPEPLD mRNA level con-
tent during hibernation may support a decrease in AEA
synthesis, and ultimately content. The tissue content in 2-
AG is decreased in winter with no changes in mRNA levels
Fig. 5 Fold change in gene expression of target genes involved in endocannabinoids biosynthesis and catabolism in brown bear adipose tissue.
Adipose tissues were collected from bears at both winter-hibernating and summer-active time points (Supplementary Table S1), total RNA was extracted
and expression levels were measured by RT-qPCR. Data are normalized against TBP mRNA levels and expressed as a fold change relative to the summer
condition, represented as mean ± SEM of separate extractions and quantifications (n = 5 for summer and n = 13 for winter samples). Unpaired Student t-
test were used to compare wummer and winter data.* indicates p value < 0.05 when comparing seasons. CNR1: cannabinoid receptor 1, CNR2:
cannabinoid receptor 2, DAGLA: diacylglycerol lipase alpha, DAGLB: diacylglycerol lipase beta, FAAH: fatty acid amide hydrolase, MGLL: monoacylglycerol
lipase, NAPEPLD: N-acyl phosphatidylethanolamine phospholipase D, SBA: summer bear adipose tissue, WBA: winter bear adipose tissue
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of the catabolic enzyme MGLL. Furthermore, opposite
changes in DAGLA and DAGLB gene expression do not
allow to speculate on the biosynthetic/degradation balance.
One limitation of our study is that gene expression could
not reflect biological activity. Moreover, we only focused
on main biosynthetic and catabolic enzymes involved in
eCBs metabolism, and investigation on alternative degrad-
ation route as endocannabinoid oxygenation by cyclooxy-
genases and lipoxygenases would bring new insights.
During hibernation, lower 2-AG (and AEA close to stat-
istical threshold) tissue content and the reduction of
CNR1 and CNR2 mRNA levels in muscle and adipose tis-
sue, respectively, strongly support reduced ECS tone in
both tissues. In non-hibernating mammals, pharmaco-
logical inhibition of CB1 leads to a decrease in PDK4 ex-
pression [25, 57]. PDK4 is a major negative regulator of
PDH activity, that in turn regulates the whole body oxida-
tive carbohydrate metabolism. In hibernating bear muscle,
recent studies have shown that PDK4 is upregulated com-
pared to summer active state [10, 58] and expression of
PDK4 during hibernation appear thus to be disconnected
from direct regulation by CB1. CB1 receptor antagonism
also leads to an increased uptake of glucose in muscle via
PI3K signaling [59], and glycolysis appears preserved in
bear skeletal muscle during hibernation, as suggested by
an overall increase in the protein abundance of all glyco-
lytic enzymes [10]. As proposed by Chazarin et al. and
Vella et al., bears still oxidize glucose and produce lactate
in skeletal muscle during hibernation [10, 60].
Overactivation of the ECS is a hallmark of obesity [61,
62], and 2-AG is predominantly found in higher concen-
tration in tissues of obese people [61, 63]. Interestingly, in
murine models of obesity, gain of adipose tissue often
leads to increased fat inflammation [36, 37]. Genetic or
pharmacological inactivation of CB2 receptor contribute
to reduce adipose tissue inflammation, increase insulin
sensitivity and skeletal muscle glucose uptake [36, 37].
Strikingly, insulin resistance has been described in hiber-
nating bears adipocytes [64]. As bears don’t experience
health consequences of circannual high body fat storage
[65], a reduced CB2 signaling in adipose tissue could
dampen adipose tissue inflammation. Lower amounts of
2-AG and AEA could also reduced CB1 signaling in adi-
pose tissue, thus limiting lipogenesis and promoting lip-
olysis during hibernation in bears, as also suggested for
hibernating marmots [30].
OEA is a high-affinity agonist for peroxisome
proliferator-activated receptor α (PPARA), regulating food
intake and stimulating fat catabolism [38, 39, 53, 66, 67].
The eCB-like OEA is generally synthesized in response to
dietary oleic acid intake by enterocytes of the small intes-
tine [49, 54], and inhibits food intake. It has already been
shown in rodents that food deprivation inhibits OEA syn-
thesis in the small intestine, but stimulates its synthesis in
liver [38, 53, 68, 69]. Therefore, during bear hibernation,
circulating OEA could originate from tissue synthesis
(probably hepatic) and be released in the blood flow. The
high OEA level that we found in hibernating bears, not trig-
gered by food intake, could participate in a sustained an-
orexigenic signal during the hibernation state.
Consequences of high levels of circulating OEA have
been studied in non-hibernating rodents. Intraperitoneal
OEA administration in rats notably impairs locomotor ac-
tivity, which is supported by a decrease in ambulation, an
increase of the time spent in inactivity, and the presence of
signs of catalepsy [66, 70]. We thus can hypothesize that a
higher amount of plasma OEA during bear hibernation can
participate in the maintenance of prolonged physical in-
activity. It has also been shown that intracerebroventricular
injections of OEA promote alertness, with the observation
of enhanced dopamine and c-Fos expressions in wake-
related brain areas [71]. Bears are known to stay sensitive
to disturbance during hibernation [72–74]. High circulating
amounts of OEA might thus participate in alertness to
external stimuli from the environment in hibernating bears.
OEA during winter possibly also favors body fat
mobilization for energy needs, with stimulation of FA and
glycerol release from adipocytes [38, 39]. Finally, a potential
role for OEA in the promotion of fasting-induced ketogen-
esis during hibernation could also be considered, as OEA
has been demonstrated to increase 3-hydroxybutyrate pro-
duction in in vivo rodent models [38, 39].
Conclusions
In conclusion, our results show a reduction in ECS tone
in hibernating bears and suggest a coordinated downreg-
ulation of CB1 and CB2 signaling in skeletal muscle and
adipose tissue. As summarized in Fig. 6, these features
could favor energy mobilization through lipolysis, and
optimization of glucose uptake by skeletal muscles.
Despite high fat stores in winter, bears do not exhibit
features of ECS overactivation, and decrease in CB2 sig-
naling could dampen adipose tissue inflammation. The
observed increase in circulating OEA level may partici-
pate in the behavioral and physiological adaptations dur-
ing bear hibernation state, like maintenance of an
anorexigenic signaling pathway, and promotion of lipoly-
sis and fatty acid β-oxidation. We also speculated about
OEA involvement in torpor maintenance and in motor
activity reduction, as well as a role in conservation of
alertness at the level of central nervous system.
Methods
Bear sample collection
A total of 28 free ranging subadult brown bears (Ursus
arctos) from Dalarna and Gävleborg counties, Sweden,
were included in this study, including 4 bears captured
two consecutive years. All samples and data were collected
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under protocols approved by the Swedish Ethical Com-
mittee on Animal Experiment (applications Dnr C3/2016
and Dnr C18/2015), the Swedish Environmental Protec-
tion Agency (NV-00741-18), and the Swedish Board of
Agriculture (Dnr 5.2.18–3060/17). All procedures com-
plied with Swedish laws and regulations.
As described previously [10, 75], blood, subcutaneous
adipose tissue, and muscle tissue (vastus lateralis) samples
were collected at two time points, in February during win-
ter hibernation (W) and in June during summer-active
period (S). Blood samples were collected from the jugular
vein into 8ml dry tubes for serum (Vacuette® Z serum Sep
Clot Activator, Greiner Bio-One GmbH, Kremsmünster,
Austria) or into 10ml EDTA-coated tubes (BD Vacutai-
ner®, FisherScientific, Illkirch, France) for plasma.
The analyses were performed on samples coming from
different subsets of bears as described in Supplementary
Table S1.
Lipid extraction and analysis
To perform serum lipidomic analysis, serum mixes were
prepared as followed: for a given year, 50 μl of summer
serum from each bear of the year was pooled to obtain the
summer mix. In parallel, 50 μl of winter serum from the
same bears was pooled to obtain the winter mix. A total of
6 summer and winter paired mixes were obtained (Sup-
plementary Table S1). Lipids were extracted and analyzed
as previously described [76]. After addition of an internal
standard (tri-17:0 triacylglycerol), total lipids were ex-
tracted twice from bear serum mixes with ethanol/chloro-
form (1:2, v/v). The organic phases were dried under
nitrogen and lipids were transmethylated. Briefly, samples
were treated with toluene-methanol (1:1, v/v) and boron
trifluoride in methanol (14%). Transmethylation was car-
ried out at 100 °C for 90min in screw-capped tubes. Then
1.5 mL K2CO3 in 10% water was added and the resulting
fatty acid methyl esters were extracted by 2mL of isooc-
tane and analyzed by gas chromatography (GC) with a
HP6890 instrument equipped with a fused silica capillary
BPX70 SGE column (60 × 0.25mm). The vector gas was
hydrogen. Temperatures of the Ross injector and the
flame ionization detector were set to 230 °C and 250 °C,
respectively. Data were expressed in mmol/L for total or
individual fatty acids (FAs) concentration or molar per-
centage of total lipids for individual FAs. Detailed lipido-
mic results are presented in supplementary Table S2
(serum fatty acid concentrations) and S3 (serum fatty acid
relative proportions).
Endocannabinoid quantification
For quantification of circulating endocannabinoids, ana-
lysis was performed on 500 μl of plasma collected at the
two time points (S and W) from 8 individual animals (see
supplementary Table S1). Standard endocannabinoids
Fig. 6 Hypothetical consequences of changes in circulating lipids and endocannabinoid system tone during hibernation in brown bear. Black
arrows represent possible behavior and metabolic outcomes
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(eCBs), i.e.- PEA, PEA-d5, OEA, OEA-d4, AEA, AEA-d4,
2AG, and 2AG-d5, were purchased from Cayman (Bertin
BioReagent, Saint-Quentin en Yvelines, France). Mass spec-
trometry quality grade solvents were purchased from Fi-
scher Scientific (Illkirch, France). Tissue samples (adipose
and muscle tissues); c.a 100mg) were crushed in an Omni
Bead Ruptor 24 apparatus (Omni International, Kennesaw,
USA) with circa twenty 1.4mm OD zirconium oxide beads
(S = 6.95m/s, T = 30s, C = 3; D = 10s) and 900 μl of metha-
nol/Tris-buffer (50mM, pH = 8) 1/1 containing 20 ng of
PEA-d5, 2 ng OEA-d4, 10 ng AEA-d4, and 20 ng 2AG-d5.
Then, each homogenate was added with 2mL of CHCl3/
MeOH (1:1, v/v) and 500 μL of Tris (50mM, pH= 8), vor-
texed and centrifuged 10min at 3000 g. The organic layer
was recovered and the upper aqueous phase was extracted
twice with chloroform (1mL). Finally, organic phases were
pooled and evaporated under vacuum.
Plasma (500 μL) were mixed with 500 μL cold methanol
containing 11 ng AEA. After protein precipitation at −
20 °C for 2 h, endocannabinoids were extracted with metha-
nol/chloroform (1:1, v/v) (5ml) and saline (1.25mL). The
organic phase was recovered and the aqueous phase was
extracted twice with chloroform (3mL). Organic phases
were finally pooled and evaporated under vacuum.
Dried extracts were solubilized with methanol (200 μL)
and centrifuged for 5min at 20,000 g. Four microliters of
the supernatant were injected into a 1200 LC system
coupled to a 6460-QqQ MS/MS system equipped with an
ESI source (Agilent technologies). Separation was achieved
on Zorbax SB-C18 2.1 × 50 mm, 1.8 μm column (Agilent
technologies) at a flow rate of 0.4 mL/min, 40 °C, with a
linear gradient of (solvent A) water containing 0.1% formic
acid and (solvent B) methanol containing 0,1% formic acid
as follows: 10% of B for 1 min, up to 85% of B in 8min,
and then 100% B for 4.5 min. Acquisition was performed
in positive Selected Reaction Monitoring (SRM) mode
(source temperature: 350 °C, nebulizer gas flow rate: 10 L/
min, 40 psi, sheath gas flow 10 L/min, sheath gas
temperature 350 °C, capillary 4000 V, nozzle 1000 V).
Transitions used were: 2AG-d5 384.3→ 91.1 (frag 120
V, CE 62 V), 2AG 379.1→ 91 (frag 120 V, CE 62 V), AEA-
d4 352.2→ 66.1 (frag 115 V, CE 14 V), AEA 348.2→ 62
(frag 120 V, CE 14 V), OEA-d4 330.2→ 66.1 (frag 120 V,
CE 14 V), OEA 326.2→ 62 (frag 115 V, CE 14 V), PEA-d5
305.2→ 62 (frag 124 V, CE 14 V), and PEA 300.2→ 62
(frag 124 V, CE 14 V).
Endocannabinoids quantification in tissues was per-
formed on tissue samples collected at the two time points
(S and W) from 5 (muscle tissue) and 6 (adipose tissue)
bears (Supplementary Table S1). eCBs from tissues were
quantitated according to the isotope dilution method. Re-
sults are expressed as pg per mg of wet weight of tissue.
eCBs from plasma were quantitated using calibration
curves obtained with authentic standards extracted by the
same method used for plasma samples. Linear regression
was applied for calculations. Results are expressed as ng of
endocannabinoid per mL of plasma.
Quantification of mRNAs by real-time RT-PCR
For mRNA quantification using RT-qPCR, total RNAs were
obtained from muscle and adipose tissues collected at the
two time points (S and W). For the muscle tissue, RNAs
were extracted from 8 bears in summer and winter, while
for adipose tissue, RNAs were extracted from 5 bears in
summer and 13 bears in winter (Supplementary Table S1).
Muscle and adipose tissue total RNA was isolated using
the TRIzol reagent (Invitrogen, Courtaboeuf, France) ac-
cording to the manufacturer’s instructions. First-strand
cDNAs were synthesized from 1 μg of total RNA using
the PrimeScript RT kit (Ozyme, saint quentin en Yveline,
France) with a mixture of random hexamers and oligo(dT)
primers, and treated with 60 units of RnaseH (Ozyme).
Real-time PCR assays were performed with Rotor-Gene
6000 (Qiagen, Courtaboeuf, France). The primers and
real-time PCR assay conditions are listed in supplemen-
tary Table S4. The results were normalized by using TBP
(TATA box binding protein) mRNA concentration, mea-
sured as reference gene in each sample.
Statistical analysis
Statistical analysis was performed using the R software
environment v3.0.2 [77]. For each set of values, distribution
of the data was tested using the Shapiro-Wilk normality
test, and using the p = 0.01 threshold normal distribution
was considered in all cases. Differences between summer
and winter data were tested using paired Student t-test for
lipidomic, endocannabinoid quantification in plasma and
tissues, and mRNA level in muscle tissue. For mRNA level
in adipose tissue, differences between summer and winter
data were tested using unpaired Student t-test. For multiple
comparison (lipidomic data), the Benjamini-Hochberg cor-
rection using the p.adjust function (Package stats version
4.0.0 of R studio) was applied. Data are presented as means
± SEM and individual values are plotted as grey and black
dots for respectively summer and winter values. Means,
SEM, fold change and associated p-values are reported
in supplementary Tables S2 to S5. Statistical signifi-
cance was considered with p values or adjusted p values
lower than 0.05.
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The online version contains supplementary material available at https://doi.
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Additional file 1 Table S1. Characteristics of brown bears included in
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